ZTS - Zoetis Inc Stock Analysis
Zoetis Inc (ZTS) is a publicly traded company listed on the . It operates in the industry, part of the broader sector. The company has a market capitalization of 31.25B, generates annual revenue of 9.51B, and reports net income of 2.64B. As of the latest data, the stock is trading at 74.53 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company is highly leveraged, which may pose risks during economic downturns or periods of rising interest rates. The stock offers a moderate dividend yield (2.87%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at No Data (None), indicating current market sentiment. Institutional ownership is reported at 101.92%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -51.24%, trading within a 52-week range of 71.47 - 160.48.
ZTS - Zoetis Inc
74.53
Analyst Consensus
No Data None
ZTS – Analyst Rating Summary
No analyst data available
No Data
| Index: | S&P 500 | P/E: | 12.35 | EPS (ttm): | 6.04 | Insider Own: | 0.61% | Shs Outstand: | 420.35M | Perf Week: | -0.76% |
| Market Cap: | 31.25B | Forward P/E: | 10.12 | EPS next Y: | 7.37 | Insider Trans: | -0.33% | Shs Float: | 416.69M | Perf Month: | -6.33% |
| Income(ttm): | 2.64B | PEG: | 1.34 | EPS next Q: | 1.85 | Inst Own: | 101.92% | Short Float: | 3.82% | Perf Quarter: | -38.46% |
| Revenue(ttm): | 9.51B | P/S: | 3.29 | EPS this Y: | 7.33% | Inst Trans: | -0.43% | Short Ratio: | 2.21 | Perf Half Y: | -40.53% |
| Book/sh: | 7.69 | P/B: | 9.69 | EPS next Y: | 7.09% | ROA: | 18.07% | Short Interest: | 15.92M | Perf Year: | -51.24% |
| Cash/sh: | 4.63 | P/C: | 16.10 | EPS next 5Y: | 7.55% | ROE: | 67.01% | 52W Range: | 71.47 - 160.48 | Perf YTD: | -40.76% |
| Dividend Est.: | 2.14 (2.87%) | P/FCF: | 14.63 | EPS past 3/5Y: | 10.25% 11.96% | ROIC: | 21.19% | 52W High: | 160.48 -53.56% | Beta: | 0.74 |
| Dividend TTM: | 2.06 (2.76%) | Quick Ratio: | 1.91 | Sales past 3/5Y: | 5.42% 7.24% | Gross Margin: | 70.43% | 52W Low: | 71.47 4.28% | Perf 5Y: | -62.78% |
| Dividend Ex-Date: | Jul 20, 2026 | Current Ratio: | 3.15 | EPS Y/Y TTM: | 8.35% | Oper. Margin: | 37.57% | RSI (14): | 40.33 | Volatility: | 2.48% 3.05% |
| Employees: | 14500 | Debt/Eq: | 2.86 | Sales Y/Y TTM: | 2.40% | Profit Margin: | 27.79% | Recom: | 1.95 | Target Price: | 108.64 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 2.86 | EPS Q/Q: | 1.02% | Payout: | 33.71% | Rel Volume: | 0.75 | Prev Close: | 74.07 |
| Sales Surprise: | -1.71% | EPS Surprise: | -4.60% | Sales Q/Q: | 1.89% | Earnings: | Aug 06 BMO | Avg Volume: | 7.19M | Price: | 74.53 |
| SMA20: | -1.54% | SMA50: | -6.49% | SMA200: | -34.94% | Undervalued: 45.77% | Volume: | 5,359,545 | Change: | 0.62% | |
Graham Classic formula value: 128.0
(P/E=8 * 1g) Min value: 84.34
(current P/E * 2g) Max value: 148.88
Average value: 120.41
About Zoetis Inc
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.